1 February 2024 in Journal of Inflammation Research
Purpose: Ischemia reperfusion injury (IRI) unavoidably occurs during lung transplantation, further contributing to primary graft dysfunction (PGD). Neutrophils are the end effectors of IRI and activated neutrophils release neutrophil extracellular traps (NETs) to further amplify damage. Nevertheless, potential contributions of NETs in IRI remain incompletely understood. This study aimed to explore NET-related gene biomarkers in IRI during lung transplantation. Methods: Differential expression analysis was applied to identify differentially expressed genes (DEGs) for IRI during lung transplantation based on matrix data (GSE145989, 127003) downloaded from GEO database. The CIBERSORT and weighted gene co-expression network analysis (WGCNA) algorithms were utilized to identify key modules associated with neutrophil infiltration. Moreover, the least absolute shrinkage and selection operator regression and random forest were applied to identify potential NET-associated hub genes. Subsequently, the screened hub genes underwent further validation of an external dataset (GSE18995) and nomogram model. Based on clinical peripheral blood samples, immunofluorescence staining and dsDNA quantification were used to assess NET formation, and ELISA was applied to validate the expression of hub genes. Results: Thirty-eight genes resulted from the intersection between 586 DEGs and 75 brown module genes, primarily enriched in leukocyte migration and NETs formation. Subsequently, four candidate hub genes (FCAR, MMP9, PADI4, and S100A12) were screened out via machine learning algorithms. Validation using an external dataset and nomogram model achieved better predictive value. Substantial NETs formation was demonstrated in IRI, with more pronounced NETs observed in patients with PGD ≥ 2. PADI4, S100A12, and MMP9 were all confirmed to be up-regulated after reperfusion through ELISA, with higher levels of S100A12 in PGD ≥ 2 patients compared with non-PGD patients. Conclusion: We identified three potential NET-related biomarkers for IRI that provide new insights into early detection and potential therapeutic targets of IRI and PGD after lung transplantation.
21 January 2025 in Clinical and Experimental Immunology
Primary graft dysfunction (PGD) represents a clinical acute lung injury syndrome occurring within 72 hours after lung transplantation, remaining the main cause of early mortality after lung transplantation. However, very few effective and specific therapies are available, except for supportive treatment. Broad cellular and molecular mechanisms contribute to PGD, yet the precise mechanism remains poorly understood. The major underlying pathophysiology of PGD is ischemia-reperfusion injury (IRI), which inevitably occurs during lung transplantation. Ischemia and subsequent reperfusion of donor lungs commonly trigger cellular and molecular dysfunction, causing disorders of metabolism and ionic homeostasis, release of reactive oxygen species (ROS), dysfunction of mitochondria, secretion of inflammatory cytokines, and activation of innate immunity. These events induce both programmed and non-programmed cell death, leading to vascular and alveolar epithelial damage, pulmonary edema, and impaired gas exchange. Innate immune activation during lung ischemia-reperfusion unfolds in two distinct phases, with the early phase primarily driven by donor-derived immune cells and the late phase mainly driven by recipient-derived immune cells. This review systematically summarizes the pathophysiology of PGD from the perspective of cellular and molecular aspects, especially emphasizing the process of programmed cell death and dynamic innate immune cell migration, which might potentially provide novel insights into the prevention and targeted therapy for IRI and PGD after lung transplantation.
1 October 2026 in Journal of Inflammation Research
Objective: People undergoing lung transplantation may develop lung ischemia-reperfusion injury (LIRI), in which neutrophils contribute to the inflammatory response. However, the molecular features associated with distinct neutrophil states remain incompletely understood. This study aimed to identify candidate molecular features associated with the immunosuppressive-II (IS-II) neutrophil state, with particular attention to NFKBIE, an NF-κB inhibitor. Methods: We integrated bulk transcriptomic and single-cell RNA-sequencing data. Candidate genes were identified using co-expression analysis and machine-learning methods. We further examined cell-cell communication and the association of NFKBIE with neutrophil states using pseudotime analysis and computational gene perturbation. We validated NFKBIE expression in a mouse model of LIRI using RT-qPCR and Western blotting and assessed lung injury by histological examination. Results: A total of 553 differentially expressed genes and a key disease-associated module containing 4,456 genes were identified, with predominant enrichment in inflammation- and immunity-related pathways (eg, TNF and NF-κB). Five overlapping candidate transcriptomic markers, CXCL3, CYLD, NFKBIE, SLC30A1, and KBTBD8, were identified. The five-gene model showed strong discrimination in the discovery cohort (AUC = 0.986) and also showed strong discrimination in the separate GSE127003 validation dataset (AUC = 0.999, 95% CI 0.996– 1.000). Single-cell analysis showed that neutrophils were the largest annotated cell population in both CIT and post-reperfusion samples, whereas the IS-II neutrophil subtype was markedly enriched after reperfusion; NFKBIE was most highly expressed in IS-II neutrophils. Pseudotime trajectory analysis further indicated that elevated NFKBIE expression was associated with a later differentiation state toward the IS-II phenotype, while computational NFKBIE perturbation predicted alterations in several perturbation-associated genes. In vivo validation confirmed that both NFKBIE mRNA and protein levels were upregulated in lung tissue after reperfusion. Conclusion: The five-gene transcriptomic model showed reproducible discriminatory performance in a separate validation dataset. NFKBIE was consistently associated with the IS-II neutrophil state across multiple computational analyses, while in vivo experiments confirmed its increased expression after reperfusion. These findings nominate NFKBIE as a candidate gene associated with IS-II neutrophil differentiation and provide a hypothesis-generating basis for further functional investigation.